Table 1 Baseline characteristics of patients treated with RFA after first-line treatment with TACE
Characteristics | No. of patients (%) |
|---|---|
Age (years) | Â |
 <60 | 27 (60.0) |
 ≥60 | 18 (40.0) |
Child-Pugh classification | Â |
 A | 45 (100.0) |
 B | 0 (0.0) |
 C | 0 (0.0) |
Gender | Â |
 Male | 39 (86.7) |
 Female | 6 (13.3) |
HBsAg | Â |
 Positive | 36 (80.0) |
 Negative | 9 (20.0) |
Anti-HCV | Â |
 Positive | 2 (4.4) |
 Negative | 43 (95.6) |
AFP | Â |
 <400 ng/ml | 25 (55.6) |
 ≥400 ng/ml | 20 (44.4) |
Ablation nodules | 84 |
 Single | 20 (23.8) |
 Multiple | 64 (76.2) |
Tumor diameter with ablation | Â |
 ≤5 cm | 44 (52.4) |
 >5 cm | 40 (47.6) |